secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chrome Holding Co. (—)
CIK:        0001804591
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001804591-24-000045
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

23andMe Q1 FY25 revenue down 34% to $40M; net loss improves to $69M; ends Therapeutics Discovery
--------------------------------------------------------------------------------

- Revenue $40M, down 34% YoY due to lower research revenue after GSK exclusivity end and lower PGS kits/telehealth.
- Net loss $69M vs $105M; adjusted EBITDA loss $35M vs $50M.
- Cash $170M, down from $216M in prior quarter.
- Ceasing Therapeutics Discovery operations effective Aug 9; terminating 30 employees.
- Officer Bill Richards resigns effective Aug 23; severance includes $253.5K lump sum, COBRA, RSU acceleration of 90,265 RSUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1804591/000180459124000045/0001804591-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1804591/000180459124000045/me-20240805.htm
  HTML page:      https://secwatch.observer/filing/0001804591-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer